Searched for
GLOBAL HOSPITAL
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- NBFCs, autos, and multi-decadal themes gain traction as India eyes post–West Asia stability boost: Nitin RahejaMarket participants are recalibrating India portfolios towards financials, autos, and long-term structural themes like defence and digital ...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- $320 billion danger: Jefferies warns 70 large EM funds are underweight IndiaDespite record FII outflows from Indian equities since September 2024, Jefferies said India remains a consensus underweight among emerging ...
- Bank of Japan raises interest rates to 31-year highThe Bank of Japan has increased its policy rate to 1.0 percent. This marks a 31-year high for interest rates. The move signals a strong foc...
- Novartis India launches Pluvicto for prostate cancer treatmentNovartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- Indian staffing cos step up global reach to diversify revenuesIndian staffing companies are actively expanding their global reach. They are tapping into international talent shortages across sectors li...
- Holiday home operator Elivaas plans new funding round; targets 1,200 villasElivaas, a holiday home operator, is preparing for its next fundraising round to fuel expansion. The company plans to double its villa coun...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- India among Marriott's fastest-growing markets; footprint to double in 5 yearsMarriott International sees India as a key growth market. The company plans to double its hotel presence in India within five years. This e...
- Physical security startup Coram AI raises $35 million co-led by Ansa Capital, Battery VenturesThe San Francisco-based company was cofounded by Ashesh Jain, formerly head of autonomy at Lyft's self-driving division, and Peter Ondruska...
- It's destination India for weddings this seasonIndian hotels are experiencing a significant rise in wedding bookings this year. This growth is driven by a preference for domestic celebra...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Assam emerges as concert hub; Rs 700 crore opportunity seen in 5 yearsAssam is becoming a top live entertainment hub in India. Progressive policies and infrastructure are boosting the economy and tourism. A re...
- S&P Global revises IPO-bound Oyo parent Prism's outlook to 'Positive'S&P Global Ratings has declared a Positive outlook for Prism, suggesting a promising trajectory for OYO's parent company. This optimistic a...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- 'Rahveers' to get Rs 25,000 reward: Nitin Gadkari announces new road safety schemesTo encourage immediate public intervention, the Ministry is introducing the "Rahveer" initiative. "If people step in to rush these 50,000 i...
Load More
